- Home
- HIPAA & Privacy
- HIPAA Notice of Privacy Practices
查找地点
有关时间、上门服务和预约This Notice of Privacy Practices (Notice) applies to Labcorp Holdings Inc. and all of its subsidiaries and business units (collectively referred to as "Labcorp" in this Notice), except to the extent that a subsidiary, division, or business unit of Labcorp performs occupational screening, forensic tests, paternity/identity tests, clinical trials tests or other services that do not involve standard electronic transactions for which the Department of Health and Human Services (HHS) has adopted standards.
Under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), Labcorp is required by law to maintain the privacy of health information that identifies you, called protected health information (PHI), and to provide you with notice of our legal duties and privacy practices regarding PHI. Labcorp is committed to the protection of your PHI and will make reasonable efforts to maintain the confidentiality of your PHI, as required by statute and regulation. We take this commitment seriously and will work with you to comply with your right to receive certain information under HIPAA.
This Notice describes how PHI may be used and disclosed and how you can get access to this information. Please review it carefully.
For more information see: https://www.hhs.gov/hipaa/for-individuals/notice-privacy-practices/index.html.
When it comes to your PHI, you have certain rights. This section explains your rights and some of Labcorp’s responsibilities.
For certain PHI, you can tell Labcorp your choices about what we disclose. If you have a clear preference for how we disclose your information in the situations described below, talk to Labcorp. Tell Labcorp what you want Labcorp to do, and we will follow your instructions.
You have both the right and choice to tell Labcorp to disclose your PHI in the following ways:
If you are not able to tell Labcorp your preference, for example if you are unconscious, we may go ahead and disclose your information if we believe it is in your best interest. We may also disclose your information when needed to lessen a serious and imminent threat to health or safety.
Labcorp will request your written permission before disclosing your PHI for marketing purposes.
Labcorp uses or discloses PHI in the following ways:
Labcorp may further use or disclose PHI, as permitted under HIPAA, in the following ways:
Labcorp has in place additional safeguards for your PHI consistent with federal and state laws, for example, relating to mental health, HIV/AIDS, and genetic testing. In addition, federally assisted alcohol and drug treatment programs are subject to additional and separate restrictions on the use and disclosure of alcohol and drug abuse treatment information. Where required, Labcorp will obtain your permission before disclosing PHI with additional safeguards to other health care providers who are not involved in your treatment program or care.
We can change the terms of this Notice, and the changes will apply to all PHI we have about you. The new Notice will be available upon request, in Labcorp’s office, and on Labcorp’s web site.
Effective Date of Notice: July 31, 2024
(877)234-4722 / (877)-23-HIPAA
HIPAA Privacy Officer, Labcorp, 531 South Spring Street, Burlington, NC 27215